Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Lipid lowering with diet or dietary supplements

INTRODUCTION

Lipid alterations can also be effected by a number of dietary approaches or specific dietary supplements [1,2]. Such approaches have been exploited by nutritionists and physicians as evidence-based and less costly alternatives to several classes of drugs. These differ with respect to mechanism of action and to the degree and type of lipid lowering. Thus, the indications for a particular dietary supplement are influenced by the underlying lipid abnormality.

The characteristics and efficacy of the lipid-lowering dietary supplements or dietary components will be reviewed here.

FISH OIL

Populations with high intakes of omega-3 (n-3) polyunsaturated fatty acids (such as the Eskimos) have low rates of heart disease; this observation has increased interest in the possible benefit of fish oils [3,4]. Rich sources of omega-3 fatty acids fatty acids come from fatty fish, especially salmon, and plant sources such as flaxseed and flaxseed oil, canola oil, soybean oil, and nuts. (See "Fish oil and marine omega-3 fatty acids" and "Dietary fat".)

Fish oil concentrate administered at high doses (>6 g/day) can reduce levels of triglycerides through inhibition of the synthesis of VLDL-triglycerides and apolipoprotein B [5,6]. In hypertriglyceridemic subjects, fish oils (in a dose of 15 g/day) lower triglyceride levels by approximately 50 percent [7,8].

Since fish oil lowers plasma triglyceride concentration, which in turn is a determinant of small dense LDL, it is possible that fish oils will decrease the concentration of smaller LDL. Support for this hypothesis comes from the observed reduction of cholesteryl ester transfer activity following fish oil therapy [9]. In addition, several studies have observed an increase in overall LDL particle size with 4 g purified docosahexaenoic acid [10-12]. In contrast, 2.5 g of omega-3 fatty acids daily for two months did not significantly change this fraction in 16 non-insulin-dependent diabetics when compared to placebo [13].

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Vogel, JH, Bolling, SF, Costello, RB, et al. Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol 2005; 46:184.
  2. Varady, KA, Jones, PJ. Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels?. J Nutr 2005; 135:1829.
  3. Rissanen, T, Voutilainen, S, Nyyssonen, K, et al. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000; 102:2677.
  4. Harper, CR, Jacobson, TA. The fats of life. The role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 2001; 161:2185.
  5. Grey, AB, Stapleton, JP, Evans, MC, Reid, IR. The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women. J Clin Endocrinol Metab 1995; 80:3191.
  6. Nestel, P, Connor, WE, Reardon, MF, et al. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984; 74:72.
  7. Harris, WS, Connor, WE, Illingworth, DR, et al. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 1990; 31:1549.
  8. Sullivan, DR, Sanders, TA, Trayner, IM, et al. Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil. Atherosclerosis 1986; 61:129.
  9. Abbey, M, Clifton, P, Kestin, M, et al. Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 1990; 10:85.
  10. Mori, TA, Burke, V, Puddey, IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000; 71:1085.
  11. Contacos, C, Barter, PJ, Sullivan, DR. Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler Thromb 1993; 13:1755.
  12. Suzukawa, M, Abbey, M, Howe, PR, Nestel, PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res 1995; 36:473.
  13. Patti, L, Maffettone, A, Iovine, C, et al. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia. Atherosclerosis 1999; 146:361.
  14. Lissin, LW, Cooke, JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000; 35:1403.
  15. Anderson, JW, Johnstone, BM, Cook-Newell, ME. Meta-analysis of the effects of soy protein intake on serum lipids [see comments]. N Engl J Med 1995; 333:276.
  16. Crouse JR, 3rd, Morgan, T, Terry, JG, et al. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999; 159:2070.
  17. Teixeira, SR, Potter, SM, Weigel, R, et al. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000; 71:1077.
  18. Sacks, FM, Lichtenstein, A, Van Horn, L, et al. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006; 113:1034.
  19. Figtree, GA, Griffiths, H, Lu, YQ, et al. Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol 2000; 35:1977.
  20. Nestel, PJ, Yamashita, T, Sasahara, T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997; 17:3392.
  21. Walker, HA, Dean, TS, Sandes, TAB, et al. The phytoestrogen genistein produces acute nitric-oxide dependent dilation of human forearm vasculature with similar potency to 17ß-estradiol. Circulation 2001; 103:258.
  22. Teede, HJ, McGrath, BP, DeSilva, L, et al. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003; 23:1066.
  23. Squadrito, F, Altavilla, D, Crisafulli, A, et al. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 2003; 114:470.
  24. Chan, YH, Lau, KK, Yiu, KH, et al. Isoflavone intake in persons at high risk of cardiovascular events: implications for vascular endothelial function and the carotid atherosclerotic burden. Am J Clin Nutr 2007; 86:938.
  25. Teede, HJ, Dalais, FS, Kotsopoulos, D, et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001; 86:3053.
  26. Li, CL, Zhu, Y, Wang, Y, et al. Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr Res 1998; 18:71.
  27. Patrick, L, Uzick, M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev 2001; 6:248.
  28. Heber, D, Yip, I, Ashley, JM, et al. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999; 69:231.
  29. Wang, J, Lu, Z, Chi, J, et al. Multicenter clinical trial of the serum lipid lowering effects of Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Cur Ther Res 1997; 58:964.
  30. Becker, DJ, Gordon, RY, Halbert, SC, et al. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 2009; 150:830.
  31. Heber, D, Lembertas, A, Lu, QY, et al. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complement Med 2001; 7:133.
  32. Red yeast rice. Med Lett Drugs Ther 2009; 51:71.
  33. Szapary, PO, Wolfe, ML, Bloedon, LT, et al. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA 2003; 290:765.
  34. Nityanand, S, Srivastava, JS, Asthana, OP. Clinical trials with gugulipid. A new hypolipidaemic agent. J Assoc Physicians India 1989; 37:323.
  35. Singh, RB, Niaz, MA, Ghosh, S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994; 8:659.
  36. Soman, CR. Indo-Mediterranean diet and progression of coronary artery disease. Lancet 2005; 366:365.
  37. Mann, J. The Indo-Mediterranean diet revisited. Lancet 2005; 366:353.
  38. Horton, R. Expression of concern: Indo-Mediterranean Diet Heart Study. Lancet 2005; 366:354.
  39. White, C. Suspected research fraud: difficulties of getting at the truth. BMJ 2005; 331:281.
  40. Chen, JT, Wesley, R, Shamburek, RD, et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy 2005; 25:171.
  41. Gouni-Berthold, I, Berthold, HK. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 2002; 143:356.
  42. Berthold, HK, Unverdorben, S, Degenhardt, R, et al. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: A randomized controlled trial. JAMA 2006; 295:2262.
  43. Isaacsohn, JL, Moser, M, Stein, EA, et al. Garlic powder and plasma lipids and lipoproteins: A multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998; 158:1189.
  44. Superko, HR, Krauss, RM. Garlic powder, effect on plasma lipids, postprandial lipemia, low- density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol 2000; 35:321.
  45. Adler, AJ, Holub, BJ. Effect of garlic and fish-oil preparations on serum lipids and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr 1997; 65:445.
  46. Steiner, M, Khan, AH, Holbert, D, Lin, R I-S. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996; 64:866.
  47. Warshafsky, S, Kamer, RS, Sivak, SL. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993; 119:599.
  48. Gylling, H, Radhakrishnan, R, Miettinen, TA. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: Women and dietary sitostanol. Circulation 1997; 96:4226.
  49. Gardner, CD, Lawson, LD, Block, E, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 2007; 167:346.
  50. Tilvis, RS, Miettinen, TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986; 43:92.
  51. Jones, PJ, MacDougall, DE, Ntanios, F, Vanstone, CA. Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 1997; 75:217.
  52. Miettinen, TA, Puska, P, Gylling, H, et al. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population [see comments]. N Engl J Med 1995; 333:1308.
  53. Weingartner, O, Bohm, M, Laufs, U. Controversial role of plant sterol esters in the management of hypercholesterolaemia. Eur Heart J 2009; :.
  54. Weingartner, O, Lutjohann, D, Ji, S, et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 2008; 51:1553.
  55. Helske, S, Miettinen, T, Gylling, H, et al. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. J Lipid Res 2008; 49:1511.
  56. Katan, MB, Grundy, SM, Jones, P, et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78:965.
  57. Weststrate, JA, Meijer, GW. Plant sterol-enriched margarines and reduction of plasma total-and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998; 52:334.
  58. Blair, SN, Capuzzi, DM, Gottlieb, SO, et al. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 2000; 86:46.
  59. Hallikainen, MA, Uusitupa, MI. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 1999; 69:403.
  60. Raeini-Sarjaz, M, Ntanios, FY, Vanstone, CA, Jones, PJ. No changes in serum fat-soluble vitamin and carotenoid concentrations with the intake of plant sterol/stanol esters in the context of a controlled diet. Metabolism 2002; 51:652.
  61. Mensink, RP, Ebbing, S, Lindhout, M, et al. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis 2002; 160:205.
  62. Mussner, MJ, Parhofer, KG, Von Bergmann, K, et al. Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 2002; 51:189.
  63. Noakes, M, Clifton, P, Ntanios, F, et al. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 2002; 75:79.
  64. Spilburg, CA, Goldberg, AC, McGill, JB, et al. Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol. J Am Diet Assoc 2003; 103:577.
  65. McPherson, TB, Ostlund, RE, Goldberg, AC, et al. Phytostanol tablets reduce human LDL-cholesterol. J Pharm Pharmacol 2005; 57:889.
  66. Goldberg, AC, Ostlund, RE Jr, Bateman, JH, et al. Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol 2006; 97:376.
  67. Allen, RR, Carson, L, Kwik-Uribe, C, et al. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J Nutr 2008; 138:725.
  68. Lichtenstein, AH, Deckelbaum, RJ. Stanol/Sterol Ester-Containing Foods and Blood Cholesterol Levels: A Statement for Healthcare Professionals From the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2001; 103:1177.
  69. Cholesterol-lowering margarines. Med Lett Drugs Ther 1999; 41:56.
  70. Zern, TL, Fernandez, ML. Cardioprotective effects of dietary polyphenols. J Nutr 2005; 135:2291.
  71. Mink, PJ, Scrafford, CG, Barraj, LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85:895.
  72. Covas, MI, Nyyssonen, K, Poulsen, HE, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 2006; 145:333.
  73. Lichtenstein, AH, Appel, LJ, Brands, M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114:82.
  74. Judd, JT, Clevidence, BA, Muesing, RA, et al. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 1994; 59:861.
  75. Lichtenstein, AH, Ausman, LM, Jalbert, SM, Schaefer, EJ. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999; 340:1933.
  76. Dreon, DM, Fernstrom, HA, Miller, B, Krauss, RM. Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 1994; 8:121.
  77. Starc, TJ, Shea, S, Cohn, LC, et al. Greater dietary intake of simple carbohydrate is associated with lower concentrations of high-density-lipoprotein cholesterol in hypercholesterolemic children. Am J Clin Nutr 1998; 67:1147.
  78. Parks, EJ, Hellerstein, MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000; 71:412.
  79. Brown, L, Rosner, B, Willett, WW, Sacks, FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69:30.
  80. Moreyra, AE, Wilson, AC, Koraym, A. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Intern Med 2005; 165:1161.
  81. Fernandez, ML. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 2001; 12:35.
  82. Roy, S, Vega-Lopez, S, Fernandez, ML. Gender and hormonal status affect the hypolipidemic mechanisms of dietary soluble fiber in guinea pigs. J Nutr 2000; 130:600.
  83. Vuksan, V, Whitham, D, Sievenpiper, JL, et al. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007; 30:2804.
  84. Shrestha, S, Volek, JS, Udani, J, et al. A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals. J Nutr 2006; 136:2492.
  85. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation 2002; 106:3143.
  86. Zambon, D, Sabate, J, Munoz, S, et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann Intern Med 2000; 132:538.
  87. Sabate, J, Fraser, GE, Burke, K, et al. Effects of walnuts on serum lipid levels and blood pressure in normal men. N Engl J Med 1993; 328:603.
  88. Ros, E, Nunez, I, Perez-Heras, A, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004; 109:1609.
  89. Sabate, J, Haddad, E, Tanzman, JS, et al. Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am J Clin Nutr 2003; 77:1379.
  90. Gebauer, SK, West, SG, Kay, CD, et al. Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study. Am J Clin Nutr 2008; 88:651.
  91. Fraser, GE, Sabate, J, Beeson, WL, Strahan, TM. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med 1992; 152:1416.
  92. Albert, CM, Gaziano, JM, Willett, WC, Manson, JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med 2002; 162:1382.
  93. Maron, DJ, Lu, GP, Cai, NS, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 2003; 163:1448.
  94. Kuriyama, S, Shimazu, T, Ohmori, K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006; 296:1255.
  95. Govers, MJ, Van der, Meet R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 1993; 34:365.
  96. Denke, MA, Fox, MM, Schulte, MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 1993; 123:1047.
  97. Bell, L, Halstenson, CE, Halstenson, CJ. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992; 152:2441.
  98. Reid, IR, Mason, B, Horne, A, et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 2002; 112:343.
  99. Bostick, RM, Fosdick, L, Grandits, GA, et al. Effect of calcium supplementation on serum cholesterol and blood pressure-a randomized, double-blind, placebo-controlled, clinical trial. Arch Fam Med 2000; 9:31.
  100. Bostick, RM, Kushi, LH, Wu, Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999; 149:151.
  101. Hsia, J, Heiss, G, Ren, H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115:846.
  102. Bolland, MJ, Barber, PA, Doughty, RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008; 336:262.
  103. Jenkins, DJ, Kendall, CW, Marchie, A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 2003; 290:502.
  104. Appel, LJ, Sacks, FM, Carey, VJ, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294:2455.
  105. de Lorgeril, M, Salen, P, Martin, JL, et al. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary heart disease. Insights into the cardioprotective effcet of certain nutriments. J Am Coll Cardiol 1996; 28:1103.
  106. Esposito, K, Marfella, R, Ciotola, M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292:1440.
  107. Estruch, R, Martinez-Gonzalez, MA, Corella, D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006; 145:1.
  108. Fito, M, Guxens, M, Corella, D, et al. Effect of a Traditional Mediterranean Diet on Lipoprotein Oxidation: A Randomized Controlled Trial. Arch Intern Med 2007; 167:1195.
  109. Knoops, KT, et al. Mediterranean diet, lifestyle factors and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292:1433.
  110. King, DE, Mainous AG, 3rd, Geesey, ME. Turning back the clock: adopting a healthy lifestyle in middle age. Am J Med 2007; 120:598.
  111. Tortosa, A, Bes-Rastrollo, M, Sanchez-Villegas, A, et al. Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 2007; 30:2957.
  112. Akesson, A, Weismayer, C, Newby, PK, Wolk, A. Combined effect of low-risk dietary and lifestyle behaviors in primary prevention of myocardial infarction in women. Arch Intern Med 2007; 167:2122.
  113. Gardner, CD, Coulston, A, Chatterjee, L, et al. The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial. Ann Intern Med 2005; 142:725.
  114. Djousse, L, Gaziano, JM. Breakfast cereals and risk of heart failure in the physicians' health study I. Arch Intern Med 2007; 167:2080.
  115. Champagne, CM. Dietary interventions on blood pressure: the Dietary Approaches to Stop Hypertension (DASH) trials. Nutr Rev 2006; 64:S53.
  116. Obarzanek, E, Sacks, FM, Vollmer, WM, et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001; 74:80.
  117. Fung, TT, Chiuve, SE, McCullough, ML, et al. Adherence to a DASH-Style Diet and Risk of Coronary Heart Disease and Stroke in Women. Arch Intern Med 2008; 168:713.
white circle LOG IN
white circle DEMO